Use access key #2 to skip to page content.
$11.96 0.53 (4.64%)
10/7/2008 11:22 AM

Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:
****

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

0

Avatar KamranatUCLA (72.29) Submitted: 4/14/08 5:49 AM : Underperform Start Price: $10.90 MNTA Score: -26.92

only CEOs make money, investors don't make any money. we are all fools. FOOL ON FOOL!

Report this Post Replies: 0 | Reply

Featured Broker Partners